(Q40833031)

24 September 2017

1 reference

title

Rationale for the clinical use of immunotoxins: monoclonal antibodies conjugated to ribosome-inactivating proteins (English)

1 reference

24 September 2017

Preijers FW

1

1 reference

24 September 2017

publication date

1 March 1993

1 reference

24 September 2017

1 reference

24 September 2017

volume

9

1 reference

24 September 2017

issue

4-5

1 reference

24 September 2017

page(s)

293-304

1 reference

Recurrent childhood lymphocytic leukemia. Clinical and cytokinetic studies of cytosine arabinoside and methotrexate for maintenance of second hematologic remission

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10428199309148526

Continuous cultures of fused cells secreting antibody of predefined specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309148526

Anti-tumour effect of chlorambucil-antibody complexes in a murine melanoma system

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309148526

Ribosome-inactivating proteins up to date

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309148526

Enzymatic properties of ribosome-inactivating proteins (RIPs) and related toxins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309148526

Blocked and non-blocked ricin immunotoxins against the CD4 antigen exhibit higher cytotoxic potency than a ricin A chain immunotoxin potentiated with ricin B chain or with a ricin B chain immunotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309148526

Expression and functional properties of genetically engineered ricin B chain lacking galactose-binding activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309148526

Immunotoxins: hybrid molecules combining high specificity and potent cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309148526

Different biological properties of the two constituent peptide chains of ricin a toxic protein inhibiting protein synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309148526

Mutations in diphtheria toxin separate binding from entry and amplify immunotoxin selectivity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309148526

Relationship between internalization and cytotoxicity of ricin A-chain immunotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309148526

Evaluation of four CD22 antibodies as ricin A chain-containing immunotoxins for the in vivo therapy of human B-cell leukemias and lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309148526

Distribution of endocytosed molecules to intracellular acidic environments correlates with immunotoxin activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309148526

Evaluation of ricin A-chain immunotoxins directed against human T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309148526

Juvenile and adult metachromatic leukodystrophy: partial restoration of arylsulfatase A (cerebroside sulfatase) activity by inhibitors of thiol proteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309148526

Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309148526

The intersubunit disulfide bridge of ricin is essential for cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309148526

Preparation and characterization of conjugates of recombinant CD4 and deglycosylated ricin A chain using different cross-linkers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309148526

Protein thiolation and reversible protein-protein conjugation. N-Succinimidyl 3-(2-pyridyldithio)propionate, a new heterobifunctional reagent

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309148526

High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin's lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309148526

Comparative biochemical, cytotoxic and pharmacokinetic properties of immunotoxins made with native ricin A chain, ricin A1 chain and recombinant ricin A chain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309148526

Immunotoxins: a clinical review of their use in the treatment of malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309148526

An anti-CD5 immunotoxin for chronic lymphocytic leukemia: enhancement of cytotoxicity with human serum albumin-monensin.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309148526

Treatment of steroid-resistant acute graft-vs-host disease by in vivo administration of an anti-T-cell ricin A chain immunotoxin.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309148526

Biochemical, cytotoxic and pharmacokinetic properties of an immunotoxin composed of a mouse monoclonal antibody Fib75 and the ribosome-inactivating protein alpha-sarcin from Aspergillus giganteus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199309148526

10.3109/10428199309148526

21 January 2018

Identifiers

DOI

1 reference

24 September 2017

1 reference